These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 54941)

  • 81. Chemotherapy for metastatic breast cancer--when is enough enough?
    Stockler M; Wilcken N; Coates A
    Eur J Cancer; 1997 Nov; 33(13):2147-8. PubMed ID: 9470799
    [No Abstract]   [Full Text] [Related]  

  • 82. Treatment of metastatic breast cancer.
    Vogel CL
    Semin Oncol Nurs; 1991 Aug; 7(3):194-9. PubMed ID: 1718024
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Choosing treatment for metastatic breast cancer.
    Br Med J (Clin Res Ed); 1983 Jan; 286(6360):222. PubMed ID: 6401535
    [No Abstract]   [Full Text] [Related]  

  • 84. Calusterone treatment of breast cancer.
    Greenspan EM
    JAMA; 1972 Apr; 220(4):588. PubMed ID: 5067137
    [No Abstract]   [Full Text] [Related]  

  • 85. Disseminated breast cancer: evaluation of hormonal therapy utilizing stilbestrol and medrogestone (AY-62022) singly and in combination.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer; 1972 Sep; 30(3):651-3. PubMed ID: 4561631
    [No Abstract]   [Full Text] [Related]  

  • 86. Tumor marking before primary chemotherapy for breast cancer.
    Reynolds HE; Lesnefsky MH; Jackson VP
    AJR Am J Roentgenol; 1999 Oct; 173(4):919-20. PubMed ID: 10511148
    [No Abstract]   [Full Text] [Related]  

  • 87. Mechanisms of treatment failure.
    Tattersall MH
    Recent Results Cancer Res; 1993; 127():43-7. PubMed ID: 8502829
    [No Abstract]   [Full Text] [Related]  

  • 88. Chemotherapy for breast cancer--a new reality for radiation therapists.
    Harris JR; Hellman S
    Int J Radiat Oncol Biol Phys; 1983 Mar; 9(3):417-8. PubMed ID: 6841196
    [No Abstract]   [Full Text] [Related]  

  • 89. [DISCUSSIONS ON MAMMARY CANCER. 3. NON-HORMONAL PALLIATIVE TREATMENT].
    LOKKERBOL H; VAN SLOOTENE ; DEN HERDERBA ; EPHRAIM KH; VAN VAERENBERGHP ; FRENKEL M; DE LANGE SA; OKKER JJ; BAARTDELAFAILLE RL
    Jaarb Kankeronderz Kankerbestrijd Ned; 1963; 13():39-50. PubMed ID: 14182749
    [No Abstract]   [Full Text] [Related]  

  • 90. Bladder cancer treatment considerations for metastatic disease.
    Hahn RG
    Semin Oncol; 1979 Jun; 6(2):236-9. PubMed ID: 90388
    [No Abstract]   [Full Text] [Related]  

  • 91. [Role of chemotherapy and hormonal therapy in the palliation of breast neoplasms].
    Pawlicki M
    Nowotwory; 1978; 28(3):251-62. PubMed ID: 82939
    [No Abstract]   [Full Text] [Related]  

  • 92. Choosing treatment for metastatic breast cancer.
    Price LA
    Br Med J (Clin Res Ed); 1983 Feb; 286(6365):643. PubMed ID: 6402184
    [No Abstract]   [Full Text] [Related]  

  • 93. [Role and limitations of chemotherapy in breast cancer].
    Cattan A; Pourny C
    Sem Hop Ther; 1976 Jan; 52(1):33-5. PubMed ID: 1257799
    [No Abstract]   [Full Text] [Related]  

  • 94. Chemotherapy for breast cancer.
    Freedman A
    Med J Aust; 1977 Aug; 2(9):267-8. PubMed ID: 916934
    [No Abstract]   [Full Text] [Related]  

  • 95. Autophagy : Moving Benchside Promises to Patient Bedsides.
    Belaid A; Ndiaye PD; Filippakis H; Roux J; Röttinger É; Graba Y; Brest P; Hofman P; Mograbi B
    Curr Cancer Drug Targets; 2015; 15(8):684-702. PubMed ID: 26452384
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Chemotherapy for breast cancer: what's new? What's useful?
    Sledge GW
    Clin Breast Cancer; 2003 Feb; 3(6):367. PubMed ID: 12636879
    [No Abstract]   [Full Text] [Related]  

  • 97. Patient selection in high-dose trials of breast cancer.
    Adkins DR; Brown RA; DiPersio JF
    J Clin Oncol; 1998 Mar; 16(3):1238-9. PubMed ID: 9508217
    [No Abstract]   [Full Text] [Related]  

  • 98. [Treatment of inoperable carcinoma patients in old age].
    Rieche K
    Z Alternsforsch; 1974; 28(1):13-7. PubMed ID: 4137482
    [No Abstract]   [Full Text] [Related]  

  • 99. The activity of phosphohexose isomerase in primary breast carcinomas and response to chemotherapy in patients with metastatic disease.
    Mitchell I; Deshpande N; Millis R; Rubens RD
    Cancer Chemother Pharmacol; 1986; 17(3):289-91. PubMed ID: 3742715
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Chemokines and breast cancer: a gateway to revolutionary targeted cancer treatments?
    Dowsland MH; Harvey JR; Lennard TW; Kirby JA; Ali S
    Curr Med Chem; 2003 Apr; 10(7):579-92. PubMed ID: 12678790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.